SLS

SELLAS Life Sciences Group, Inc.

Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001390478 Biotech & Drug Discovery

$12.17 +0.83 (+7.32%)

Oct 27 4:00 PM ET · prev $11.34

Market cap

$2.3B

Mid cap

Median target

$32.50

+167% · range $30.00–35.00

Next earnings

Nov 10

in 14 days · EPS est. −$0.05

1 year

+508.5%

from $2.00 · Oct 28

30 days

+5.0%

from $11.59

52-week range

$1.39–15.46

−21% from high · low Dec 2

Avg volume 20D

5.75M

Oct 16 spike 15.82M

Short interest

53.76M

≈26.6% of shares · −2.5%

Days to cover

11.9

at average volume

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Reddit crowd

66°

Warm · 12 mentions this week

SecBot read MIXED 2 reports · 90 days

Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 1/2 ·Next Earnings date, Nov 10, 2026

Strongest NEUTRAL SELLAS Life Sciences presented preclinical data at AACR showing its CDK9 inhibitor SLS009 induced…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsBULLISH

Q2 2026: 30 added (0 new), 5 trimmed or exited.
EstimatesRISING

Current-quarter EPS estimate −$0.055 → −$0.050 over 90 days.
Short sellersSTEADY

Short interest −2.5% to 53.76M shares. 11.9 days to cover, ≈26.6% of shares.
TrendDOWNTREND

2% below its 50-day average.
SocialQUIET

Crowd 66° (warm) this week from 12 mentions: 5 bullish, 0 bearish. No setup call. Excludes 1 subscriber-only day.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
STATE STREET CORP	ADD	12,996,558	$191.8M
VANGUARD PORTFOLIO MANAGEMENT LLC	ADD	2,161,099	$31.9M
SUSQUEHANNA INTERNATIONAL GROUP, LLP	DOUBLED	2,050,597	$30.3M
JONES FINANCIAL COMPANIES LLLP	ADD	2,304,561	$28.6M
NORTHERN TRUST CORP	ADD	1,619,928	$23.9M
UBS Group AG	ADD	1,252,757	$18.5M
BNP PARIBAS FINANCIAL MARKETS	DOUBLED	1,072,022	$15.8M
WELLINGTON MANAGEMENT GROUP LLP	ADD	597,309	$8.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2026

12-month targets · 2 analysts

$12.17 $30.00 $32.50 $35.00

Price is below the lowest target. Median implies +167%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Mar 12, 2026	Maxim Group MAINTAIN	MAINTAIN	Buy
Jul 16, 2025	Maxim Group MAINTAIN	MAINTAIN	Buy
Nov 22, 2023	Cantor Fitzgerald REITERATE	REITERATE	Overweight
Sep 7, 2023	Cantor Fitzgerald REITERATE	REITERATE	Overweight
Nov 15, 2022	Alliance Global Partners MAINTAIN	MAINTAIN	Buy
Jun 28, 2022	Cantor Fitzgerald MAINTAIN	MAINTAIN	Overweight

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Jun 16, 2026	Stergiou Angelos M. President and CEO	AWARD	1,065,000 sh

Earnings setup

Estimates

Nov 10

reports in 14 days

−$0.05

EPS estimate, this quarter

+9%

estimate change, 90 days

Current-quarter EPS estimate

−$0.055

90d

−$0.055

60d

−$0.055

30d

−$0.055

−$0.050

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.05	-$0.05–-$0.05	+9.1%	$0.00
Next Q	-$0.05	-$0.05–-$0.05	+9.1%	$0.00
Current FY	-$0.20	-$0.20–-$0.20	+4.8%	$0.00
Next FY	-$0.10	-$0.20–$0.00	+20.0%	$53.1M